Navigation Links
BioSpecifics Technologies Corp. To Present at BioCentury 'NewsMakers in the Biotech Industry' Conference
Date:9/11/2009

LYNBROOK, N.Y., Sept. 11 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming BioCentury "NewsMakers in the Biotech Industry" Conference on Wednesday, September 16, 2009, at 9:00 am ET at the Millennium Broadway Hotel & Conference Center in New York, NY.

A live webcast of the presentation can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com, or you may use the link: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=BSTC&item_id=2413263.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for three clinical indications: Dupuytren's disease; Peyronie's disease; and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium Pharmaceuticals, Inc. has announced the acceptance of the Biologic License Application (BLA) and Priority Review by the U.S. Food and Drug Administration for injectable collagenase XIAFLEX(TM) in the treatment of Dupuytren's disease. Pfizer, Inc. is responsible for marketing XIAFLEX product in Europe.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
2. BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
3. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
4. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
5. BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
6. BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
7. BioSpecifics Technologies Corp. Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytrens Disease
8. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
9. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
10. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... (PRWEB) April 25, 2015 Join us ... 29th: Analyzing Kinase Inhibitor Residence Times using the Transcreener® ... of inhibitor residence times is increasingly being incorporated into ... can result in improved efficacy, increased therapeutic window and ... determined using immobilized ligand methods such surface plasmon resonance, ...
(Date:4/24/2015)... Top student social innovators from the University ... including UCSD and SDSU, will pitch their impact ideas ... and nonprofit companies for an opportunity to win $75,000 ... Innovation Challenge 2015 . , The 2015 Social Innovation ... a diverse range of issues including poverty, education, economic ...
(Date:4/24/2015)... City, SD and Tempe, AZ (PRWEB) April 24, 2015 ... & Technology and Arizona State University (ASU) have entered ... other joint projects. , A memorandum of agreement signed ... research, long distance learning, student success and other services ... natural resources. , “We have complementary strengths and ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Leading ... milestones in its allogeneic stem-cell product development program ... properly reflect the corporate strategic direction. , “I ... (donor) adipose stem cell development program has been ... our cGMP manufacturing facility and hiring of our ...
Breaking Biology Technology:BellBrook Labs Webinar: Analyzing Kinase Inhibitor Residence Times using the Transcreener® ADP Assay 25th Annual Social Innovation Challenge at University of San Diego - Students Pitch to Live Judging Panel to Take Home $75K 25th Annual Social Innovation Challenge at University of San Diego - Students Pitch to Live Judging Panel to Take Home $75K 3South Dakota Mines, Arizona State University Pave Way for Cooperative Research 2Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma 2
... Millennium,Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) ... as Executive Vice President of,International Sales and a ... over 30 years of experience in the pharmaceutical ... into,international markets., As Executive Vice President of ...
... Sirnaomics, Inc., (http://www.sirnaomics.com ) announced today that ... innovation research) grant from National Cancer Institute,(NCI), ... a,biopharmaceutical company founded in early 2007, is ... novel targeted therapeutic,development. The company,s multi-targeted siRNA ...
... SuperGen Inc.,(Nasdaq: SUPG ), a pharmaceutical company ... today announced that it will release,its 2008 third quarter ... will provide details of the Company,s financial,results and any ... will be transmitted to the news media immediately,following the ...
Cached Biology Technology:Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales 2Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales 3Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 3SuperGen to Announce 2008 Third Quarter Financial Results November 4, 2008 2
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... exported all over the world in the form of frozen semen, ... not freeze well. In an attempt to improve semen storage and ... at how sperm survives in the sow oviduct. "Many mammals ... associate professor of animal sciences David Miller. "Pigs will store sperm ...
... discovered a new mechanism that controls egg cell fertility ... revealed by Professor Dr. Walter Stcker of the Institute ... the blood protein fetuin-B plays an important and previously ... identified in the year 2000, is formed in the ...
... American Association of Pharmaceutical Scientists is a professional, ... academia, industry, government and other research institutes worldwide. ... forum for the exchange of knowledge among scientists ... to health. AAPS offers timely scientific programs, on-going ...
Cached Biology News:Improving survival of pig sperm 2Important fertility mechanism discovered 22013 AAPS National Biotechnology Conference returns to San Diego 2
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
... Precision-designed for Optimal Microdissection , ... enable the precise and rapid extraction of ... and cytology samples with Laser Capture Microdissection., ... for Downstream Molecular Analysis , All CapSure ...
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
Hybridizer (220 V) For more information, please visit Dako' web-site. EU regulatory status: CE US regulatory status: IVD...
Biology Products: